These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34604079)
1. Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights Dong X; Jin C; Chen D; Chen Y; Ye ZQ; Zhang X; Huang X; Zhang W; Gu DN Front Oncol; 2021; 11():737867. PubMed ID: 34604079 [TBL] [Abstract][Full Text] [Related]
2. A New Ferroptosis-Related Long Non-Coding RNA Risk Model Predicts the Prognosis of Patients With Papillary Thyroid Cancer. Zhao JY; Yao JM; Zhang XZ; Wang KL; Jiang S; Guo SY; Sheng QQ; Liao L; Dong JJ World J Oncol; 2024 Aug; 15(4):648-661. PubMed ID: 38993258 [TBL] [Abstract][Full Text] [Related]
3. Survival-Related lncRNA Landscape Analysis Identifies Wu H; Zhou J; Chen S; Zhu L; Jiang M; Liu A Front Genet; 2021; 12():698947. PubMed ID: 34691143 [No Abstract] [Full Text] [Related]
4. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma. Li S; Ran MY; Qiao H Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer. Wang Y; Song B; Zhu L; Zhang X PeerJ; 2019; 7():e7976. PubMed ID: 31741788 [TBL] [Abstract][Full Text] [Related]
6. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer. Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer. Li H; Han Q; Chen Y; Chen X; Ma R; Chang Q; Yin D Am J Transl Res; 2019; 11(9):5457-5471. PubMed ID: 31632522 [TBL] [Abstract][Full Text] [Related]
8. LncRNA FOXD2-AS1 accelerates the papillary thyroid cancer progression through regulating the miR-485-5p/KLK7 axis. Zhang Y; Hu J; Zhou W; Gao H J Cell Biochem; 2019 May; 120(5):7952-7961. PubMed ID: 30456805 [TBL] [Abstract][Full Text] [Related]
9. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer. Li H; Liu F; Wang X; Li M; Li Z; Xie Y; Guo Y Front Pharmacol; 2021; 12():748867. PubMed ID: 34721037 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer. Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma. Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z Front Genet; 2022; 13():874673. PubMed ID: 35547247 [No Abstract] [Full Text] [Related]
12. Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer Sheng W; Zhou W; Cao Y; Zhong Y Front Oncol; 2021; 11():769563. PubMed ID: 35083139 [TBL] [Abstract][Full Text] [Related]
13. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature. Jing L; Du Y; Fu D Front Genet; 2022; 13():979575. PubMed ID: 36105083 [TBL] [Abstract][Full Text] [Related]
14. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma. Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M Front Oncol; 2022; 12():1019011. PubMed ID: 36387102 [TBL] [Abstract][Full Text] [Related]
15. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function. Tian X; Hu D; Wang N; Zhang L; Wang X Front Genet; 2024; 15():1337525. PubMed ID: 38655053 [TBL] [Abstract][Full Text] [Related]
16. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma. Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X Front Genet; 2021; 12():720013. PubMed ID: 34777461 [No Abstract] [Full Text] [Related]
17. The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma. Wang Y; Li X; Huang Y; Gang Q; Liu M; Zhang H; Shen S; Qi Y; Zhang J J Inflamm Res; 2024; 17():1995-2008. PubMed ID: 38566983 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database. Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma. Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975 [TBL] [Abstract][Full Text] [Related]
20. Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning. Yang F; Zhang J; Li B; Zhao Z; Liu Y; Zhao Z; Jing S; Wang G Int J Endocrinol; 2021; 2021():3984463. PubMed ID: 34335744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]